Filing Details
- Accession Number:
- 0001484612-22-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-04 17:16:33
- Reporting Period:
- 2022-04-01
- Accepted Time:
- 2022-04-04 17:16:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484612 | Outset Medical Inc. | OM | Electromedical & Electrotherapeutic Apparatus (3845) | 200514392 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870610 | Nabeel Ahmed | 3052 Orchard Drive San Jose CA 95134 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-01 | 100 | $9.48 | 44,589 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-01 | 100 | $45.19 | 44,489 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-01 | 200 | $9.48 | 44,689 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-01 | 200 | $45.19 | 44,489 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Options (right to buy) | Disposition | 2022-04-01 | 100 | $0.00 | 100 | $9.48 |
| Common Stock | Performance Options (right to buy) | Disposition | 2022-04-01 | 200 | $0.00 | 200 | $9.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,532 | 2030-05-26 | No | 4 | M | Direct | |
| 10,332 | 2030-05-26 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 22, 2022.
- This performance option vested on March 15, 2021, upon meeting the performance measures set forth in the Grant Agreement.
Billionaire Hedge Funds
